Armistice Capital’s SeaStar Medical ICU Stock Holding History

Armistice Capital’s Portfolio ICU Stock Details ICU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-61,324	Closed	-$1.02M	–	234
2025 Q1	$1.02M	Buy	+61,324	New	+$1.15M	0.02%	164

Other funds holding ICU

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TWP

Tyche Wealth Partners Plano, Texas $648M AUM 20.17% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

TFA

Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Armistice Capital's ICU Position: Q2 2025 in Review

Armistice Capital sold out of SeaStar Medical (ICU) in Q2 2025, closing a stake of 61,324 shares — an estimated $1.02M sold.

Armistice Capital first reported a position in ICU in Q1 2025 and held it in 1 quarter. The position peaked at $1.02M in Q1 2025. 26 funds tracked by Wall St. Rank hold ICU as of Q2 2025.

Armistice Capital reported no remaining SeaStar Medical position as of Q2 2025 after selling out during the quarter.
Armistice Capital sold 61,324 SeaStar Medical shares in Q2 2025, an estimated $1.02M.
Armistice Capital first reported a position in SeaStar Medical in Q1 2025 and held it in 1 quarter.
Armistice Capital's SeaStar Medical position peaked at $1.02M in Q1 2025.
26 funds tracked by Wall St. Rank held SeaStar Medical as of Q2 2025.

Based on Armistice Capital's 13F filing for Q2 2025, filed 14 Aug 2025.